Valley View, Ohio-based Great Lakes NeuroTechnologies (GLNT) which uses tablets and wearable sensors for Parkinson’s diagnosis and therapy, has published a new study looking at how wearable technology can lead to increased referral rates for therapies in Parkinson’s disease.
The small study, which was published in the Journal of Parkinson’s Disease, found that monitoring patients remotely enabled...
Great Lakes NeuroTechnologies, a company using tablets and wearable sensors for Parkinson's diagnosis and therapy, will use a recent $1.5 million NIH grant to start a move toward direct-to-consumer marketability. This is the latest in a long series of NIH grants for the company since 2005 and brings the company's total grants to $14.2 million.
The system, called Kinesia HomeView, is currently...
A British mathematician is applying "big data" algorithms to detect Parkinson's disease from voice recordings and now claims accuracy up to 99 percent.
"We also know how to predict the severity of symptoms to within a few percentage points of clinical judgment," Max Little, a mathematician on the faculty of Aston University in Birmingham, England, and a visiting researcher at both the...
It's one thing to detect the telltale stiffness, tremors, spasms and loss of muscle control of Parkinson's disease with wireless sensors, as Great Lakes Neurotechnologies is doing with its Kinesia HomeView system. It's another to add automatic medication administration to this type of technology.
A multi-country project funded by the European Union aims to do just that. Researchers in Spain,...
Parkinson's disease is considered a movement disorder, so it lends itself quite well to mobile technologies. At least one tablet-based device to measure Parkinsonian tremors is already on the market, while an iPhone measurement system passed muster in a clinical trial more than a year ago.
Two weeks ago at the AdvaMed 2011 medical technology conference in Washington, D.C., Great Lakes...
